0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pulmonary Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-27S11979
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pulmonary Drug Delivery Devices Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Pulmonary Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27S11979
Report
September 2024
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pulmonary Drug Delivery Devices - Market Size

The global market for Pulmonary Drug Delivery Devices was estimated to be worth US$ 2835.6 million in 2023 and is forecast to a readjusted size of US$ 3899 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Pulmonary Drug Delivery Devices - Market

Pulmonary Drug Delivery Devices - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pulmonary Drug Delivery Devices by region & country, by Type, and by Application.
The Pulmonary Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices.
Market Segmentation

Scope of Pulmonary Drug Delivery Devices - Market Report

Report Metric Details
Report Name Pulmonary Drug Delivery Devices - Market
Forecasted market size in 2030 US$ 3899 million
CAGR 4.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Nebulizer
Segment by Application
  • Asthma
  • COPD
  • Cystic Fibrosis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb, Mylan N.V, Omron Corp, F. Hoffmann-La Roche, 3M Healthcare, Sunovion Pharmaceuticals, Koninklijke Philips N.V, Gerresheimer AG, Bespak, AptarGroup, SHL Group, Nypro Healthcare, Hovione, Chiesi Farmaceutici S.P.A
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Pulmonary Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pulmonary Drug Delivery Devices - Market size in 2030?

Ans: The Pulmonary Drug Delivery Devices - Market size in 2030 will be US$ 3899 million.

Who are the main players in the Pulmonary Drug Delivery Devices - Market report?

Ans: The main players in the Pulmonary Drug Delivery Devices - Market are Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb, Mylan N.V, Omron Corp, F. Hoffmann-La Roche, 3M Healthcare, Sunovion Pharmaceuticals, Koninklijke Philips N.V, Gerresheimer AG, Bespak, AptarGroup, SHL Group, Nypro Healthcare, Hovione, Chiesi Farmaceutici S.P.A

What are the Application segmentation covered in the Pulmonary Drug Delivery Devices - Market report?

Ans: The Applications covered in the Pulmonary Drug Delivery Devices - Market report are Asthma, COPD, Cystic Fibrosis, Other

What are the Type segmentation covered in the Pulmonary Drug Delivery Devices - Market report?

Ans: The Types covered in the Pulmonary Drug Delivery Devices - Market report are Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer

1 Market Overview
1.1 Pulmonary Drug Delivery Devices Product Introduction
1.2 Global Pulmonary Drug Delivery Devices Market Size Forecast
1.2.1 Global Pulmonary Drug Delivery Devices Sales Value (2019-2030)
1.2.2 Global Pulmonary Drug Delivery Devices Sales Volume (2019-2030)
1.2.3 Global Pulmonary Drug Delivery Devices Sales Price (2019-2030)
1.3 Pulmonary Drug Delivery Devices Market Trends & Drivers
1.3.1 Pulmonary Drug Delivery Devices Industry Trends
1.3.2 Pulmonary Drug Delivery Devices Market Drivers & Opportunity
1.3.3 Pulmonary Drug Delivery Devices Market Challenges
1.3.4 Pulmonary Drug Delivery Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pulmonary Drug Delivery Devices Players Revenue Ranking (2023)
2.2 Global Pulmonary Drug Delivery Devices Revenue by Company (2019-2024)
2.3 Global Pulmonary Drug Delivery Devices Players Sales Volume Ranking (2023)
2.4 Global Pulmonary Drug Delivery Devices Sales Volume by Company Players (2019-2024)
2.5 Global Pulmonary Drug Delivery Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Pulmonary Drug Delivery Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pulmonary Drug Delivery Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pulmonary Drug Delivery Devices
2.9 Pulmonary Drug Delivery Devices Market Competitive Analysis
2.9.1 Pulmonary Drug Delivery Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pulmonary Drug Delivery Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dry Powder Inhaler
3.1.2 Metered Dose Inhaler
3.1.3 Nebulizer
3.2 Global Pulmonary Drug Delivery Devices Sales Value by Type
3.2.1 Global Pulmonary Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pulmonary Drug Delivery Devices Sales Value, by Type (2019-2030)
3.2.3 Global Pulmonary Drug Delivery Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Pulmonary Drug Delivery Devices Sales Volume by Type
3.3.1 Global Pulmonary Drug Delivery Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pulmonary Drug Delivery Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Pulmonary Drug Delivery Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Pulmonary Drug Delivery Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Asthma
4.1.2 COPD
4.1.3 Cystic Fibrosis
4.1.4 Other
4.2 Global Pulmonary Drug Delivery Devices Sales Value by Application
4.2.1 Global Pulmonary Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pulmonary Drug Delivery Devices Sales Value, by Application (2019-2030)
4.2.3 Global Pulmonary Drug Delivery Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Pulmonary Drug Delivery Devices Sales Volume by Application
4.3.1 Global Pulmonary Drug Delivery Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pulmonary Drug Delivery Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Pulmonary Drug Delivery Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Pulmonary Drug Delivery Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pulmonary Drug Delivery Devices Sales Value by Region
5.1.1 Global Pulmonary Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pulmonary Drug Delivery Devices Sales Value by Region (2019-2024)
5.1.3 Global Pulmonary Drug Delivery Devices Sales Value by Region (2025-2030)
5.1.4 Global Pulmonary Drug Delivery Devices Sales Value by Region (%), (2019-2030)
5.2 Global Pulmonary Drug Delivery Devices Sales Volume by Region
5.2.1 Global Pulmonary Drug Delivery Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pulmonary Drug Delivery Devices Sales Volume by Region (2019-2024)
5.2.3 Global Pulmonary Drug Delivery Devices Sales Volume by Region (2025-2030)
5.2.4 Global Pulmonary Drug Delivery Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Pulmonary Drug Delivery Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pulmonary Drug Delivery Devices Sales Value, 2019-2030
5.4.2 North America Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pulmonary Drug Delivery Devices Sales Value, 2019-2030
5.5.2 Europe Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pulmonary Drug Delivery Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pulmonary Drug Delivery Devices Sales Value, 2019-2030
5.7.2 South America Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value
6.2.1 Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pulmonary Drug Delivery Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.3.2 United States Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.4.2 Europe Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.5.2 China Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.6.2 Japan Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.7.2 South Korea Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pulmonary Drug Delivery Devices Sales Value, 2019-2030
6.9.2 India Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pulmonary Drug Delivery Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Information
7.1.2 Boehringer Ingelheim GmbH Introduction and Business Overview
7.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Offerings
7.1.5 Boehringer Ingelheim GmbH Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Company Information
7.2.2 Novartis AG Introduction and Business Overview
7.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis AG Pulmonary Drug Delivery Devices Product Offerings
7.2.5 Novartis AG Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Information
7.3.2 GlaxoSmithKline Introduction and Business Overview
7.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Product Offerings
7.3.5 GlaxoSmithKline Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca Pulmonary Drug Delivery Devices Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Company Information
7.5.2 Teva Pharmaceutical Industries Introduction and Business Overview
7.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Offerings
7.5.5 Teva Pharmaceutical Industries Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Introduction and Business Overview
7.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Pulmonary Drug Delivery Devices Product Offerings
7.6.5 Merck Recent Development
7.7 MannKind
7.7.1 MannKind Company Information
7.7.2 MannKind Introduction and Business Overview
7.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 MannKind Pulmonary Drug Delivery Devices Product Offerings
7.7.5 MannKind Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Information
7.8.2 Bristol-Myers Squibb Introduction and Business Overview
7.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Offerings
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Mylan N.V
7.9.1 Mylan N.V Company Information
7.9.2 Mylan N.V Introduction and Business Overview
7.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Mylan N.V Pulmonary Drug Delivery Devices Product Offerings
7.9.5 Mylan N.V Recent Development
7.10 Omron Corp
7.10.1 Omron Corp Company Information
7.10.2 Omron Corp Introduction and Business Overview
7.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Omron Corp Pulmonary Drug Delivery Devices Product Offerings
7.10.5 Omron Corp Recent Development
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Company Information
7.11.2 F. Hoffmann-La Roche Introduction and Business Overview
7.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Offerings
7.11.5 F. Hoffmann-La Roche Recent Development
7.12 3M Healthcare
7.12.1 3M Healthcare Company Information
7.12.2 3M Healthcare Introduction and Business Overview
7.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.12.4 3M Healthcare Pulmonary Drug Delivery Devices Product Offerings
7.12.5 3M Healthcare Recent Development
7.13 Sunovion Pharmaceuticals
7.13.1 Sunovion Pharmaceuticals Company Information
7.13.2 Sunovion Pharmaceuticals Introduction and Business Overview
7.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Offerings
7.13.5 Sunovion Pharmaceuticals Recent Development
7.14 Koninklijke Philips N.V
7.14.1 Koninklijke Philips N.V Company Information
7.14.2 Koninklijke Philips N.V Introduction and Business Overview
7.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Offerings
7.14.5 Koninklijke Philips N.V Recent Development
7.15 Gerresheimer AG
7.15.1 Gerresheimer AG Company Information
7.15.2 Gerresheimer AG Introduction and Business Overview
7.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Product Offerings
7.15.5 Gerresheimer AG Recent Development
7.16 Bespak
7.16.1 Bespak Company Information
7.16.2 Bespak Introduction and Business Overview
7.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Bespak Pulmonary Drug Delivery Devices Product Offerings
7.16.5 Bespak Recent Development
7.17 AptarGroup
7.17.1 AptarGroup Company Information
7.17.2 AptarGroup Introduction and Business Overview
7.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.17.4 AptarGroup Pulmonary Drug Delivery Devices Product Offerings
7.17.5 AptarGroup Recent Development
7.18 SHL Group
7.18.1 SHL Group Company Information
7.18.2 SHL Group Introduction and Business Overview
7.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.18.4 SHL Group Pulmonary Drug Delivery Devices Product Offerings
7.18.5 SHL Group Recent Development
7.19 Nypro Healthcare
7.19.1 Nypro Healthcare Company Information
7.19.2 Nypro Healthcare Introduction and Business Overview
7.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Product Offerings
7.19.5 Nypro Healthcare Recent Development
7.20 Hovione
7.20.1 Hovione Company Information
7.20.2 Hovione Introduction and Business Overview
7.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Hovione Pulmonary Drug Delivery Devices Product Offerings
7.20.5 Hovione Recent Development
7.21 Chiesi Farmaceutici S.P.A
7.21.1 Chiesi Farmaceutici S.P.A Company Information
7.21.2 Chiesi Farmaceutici S.P.A Introduction and Business Overview
7.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Offerings
7.21.5 Chiesi Farmaceutici S.P.A Recent Development
8 Industry Chain Analysis
8.1 Pulmonary Drug Delivery Devices Industrial Chain
8.2 Pulmonary Drug Delivery Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pulmonary Drug Delivery Devices Sales Model
8.5.2 Sales Channel
8.5.3 Pulmonary Drug Delivery Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pulmonary Drug Delivery Devices Market Trends
    Table 2. Pulmonary Drug Delivery Devices Market Drivers & Opportunity
    Table 3. Pulmonary Drug Delivery Devices Market Challenges
    Table 4. Pulmonary Drug Delivery Devices Market Restraints
    Table 5. Global Pulmonary Drug Delivery Devices Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pulmonary Drug Delivery Devices Revenue Market Share by Company (2019-2024)
    Table 7. Global Pulmonary Drug Delivery Devices Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Pulmonary Drug Delivery Devices Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Pulmonary Drug Delivery Devices Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Pulmonary Drug Delivery Devices Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Pulmonary Drug Delivery Devices Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Pulmonary Drug Delivery Devices
    Table 13. Global Pulmonary Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pulmonary Drug Delivery Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Pulmonary Drug Delivery Devices Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Pulmonary Drug Delivery Devices Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Pulmonary Drug Delivery Devices Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Pulmonary Drug Delivery Devices Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Pulmonary Drug Delivery Devices Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Pulmonary Drug Delivery Devices Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Pulmonary Drug Delivery Devices Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Pulmonary Drug Delivery Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Pulmonary Drug Delivery Devices Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Pulmonary Drug Delivery Devices Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Pulmonary Drug Delivery Devices Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Pulmonary Drug Delivery Devices Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Pulmonary Drug Delivery Devices Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Pulmonary Drug Delivery Devices Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Pulmonary Drug Delivery Devices Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Pulmonary Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Pulmonary Drug Delivery Devices Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Pulmonary Drug Delivery Devices Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Pulmonary Drug Delivery Devices Sales Value by Region (2019-2024) & (%)
    Table 44. Global Pulmonary Drug Delivery Devices Sales Value by Region (2025-2030) & (%)
    Table 45. Global Pulmonary Drug Delivery Devices Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Pulmonary Drug Delivery Devices Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Pulmonary Drug Delivery Devices Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Pulmonary Drug Delivery Devices Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Pulmonary Drug Delivery Devices Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Pulmonary Drug Delivery Devices Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Pulmonary Drug Delivery Devices Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Volume, (2025-2030) & (K Units)
    Table 57. Boehringer Ingelheim GmbH Company Information
    Table 58. Boehringer Ingelheim GmbH Introduction and Business Overview
    Table 59. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Offerings
    Table 61. Boehringer Ingelheim GmbH Recent Development
    Table 62. Novartis AG Company Information
    Table 63. Novartis AG Introduction and Business Overview
    Table 64. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Novartis AG Pulmonary Drug Delivery Devices Product Offerings
    Table 66. Novartis AG Recent Development
    Table 67. GlaxoSmithKline Company Information
    Table 68. GlaxoSmithKline Introduction and Business Overview
    Table 69. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. GlaxoSmithKline Pulmonary Drug Delivery Devices Product Offerings
    Table 71. GlaxoSmithKline Recent Development
    Table 72. AstraZeneca Company Information
    Table 73. AstraZeneca Introduction and Business Overview
    Table 74. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. AstraZeneca Pulmonary Drug Delivery Devices Product Offerings
    Table 76. AstraZeneca Recent Development
    Table 77. Teva Pharmaceutical Industries Company Information
    Table 78. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 79. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Offerings
    Table 81. Teva Pharmaceutical Industries Recent Development
    Table 82. Merck Company Information
    Table 83. Merck Introduction and Business Overview
    Table 84. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Merck Pulmonary Drug Delivery Devices Product Offerings
    Table 86. Merck Recent Development
    Table 87. MannKind Company Information
    Table 88. MannKind Introduction and Business Overview
    Table 89. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. MannKind Pulmonary Drug Delivery Devices Product Offerings
    Table 91. MannKind Recent Development
    Table 92. Bristol-Myers Squibb Company Information
    Table 93. Bristol-Myers Squibb Introduction and Business Overview
    Table 94. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Offerings
    Table 96. Bristol-Myers Squibb Recent Development
    Table 97. Mylan N.V Company Information
    Table 98. Mylan N.V Introduction and Business Overview
    Table 99. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Mylan N.V Pulmonary Drug Delivery Devices Product Offerings
    Table 101. Mylan N.V Recent Development
    Table 102. Omron Corp Company Information
    Table 103. Omron Corp Introduction and Business Overview
    Table 104. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Omron Corp Pulmonary Drug Delivery Devices Product Offerings
    Table 106. Omron Corp Recent Development
    Table 107. F. Hoffmann-La Roche Company Information
    Table 108. F. Hoffmann-La Roche Introduction and Business Overview
    Table 109. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Offerings
    Table 111. F. Hoffmann-La Roche Recent Development
    Table 112. 3M Healthcare Company Information
    Table 113. 3M Healthcare Introduction and Business Overview
    Table 114. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. 3M Healthcare Pulmonary Drug Delivery Devices Product Offerings
    Table 116. 3M Healthcare Recent Development
    Table 117. Sunovion Pharmaceuticals Company Information
    Table 118. Sunovion Pharmaceuticals Introduction and Business Overview
    Table 119. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Offerings
    Table 121. Sunovion Pharmaceuticals Recent Development
    Table 122. Koninklijke Philips N.V Company Information
    Table 123. Koninklijke Philips N.V Introduction and Business Overview
    Table 124. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Offerings
    Table 126. Koninklijke Philips N.V Recent Development
    Table 127. Gerresheimer AG Company Information
    Table 128. Gerresheimer AG Introduction and Business Overview
    Table 129. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Gerresheimer AG Pulmonary Drug Delivery Devices Product Offerings
    Table 131. Gerresheimer AG Recent Development
    Table 132. Bespak Company Information
    Table 133. Bespak Introduction and Business Overview
    Table 134. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Bespak Pulmonary Drug Delivery Devices Product Offerings
    Table 136. Bespak Recent Development
    Table 137. AptarGroup Company Information
    Table 138. AptarGroup Introduction and Business Overview
    Table 139. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. AptarGroup Pulmonary Drug Delivery Devices Product Offerings
    Table 141. AptarGroup Recent Development
    Table 142. SHL Group Company Information
    Table 143. SHL Group Introduction and Business Overview
    Table 144. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. SHL Group Pulmonary Drug Delivery Devices Product Offerings
    Table 146. SHL Group Recent Development
    Table 147. Nypro Healthcare Company Information
    Table 148. Nypro Healthcare Introduction and Business Overview
    Table 149. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Nypro Healthcare Pulmonary Drug Delivery Devices Product Offerings
    Table 151. Nypro Healthcare Recent Development
    Table 152. Hovione Company Information
    Table 153. Hovione Introduction and Business Overview
    Table 154. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Hovione Pulmonary Drug Delivery Devices Product Offerings
    Table 156. Hovione Recent Development
    Table 157. Chiesi Farmaceutici S.P.A Company Information
    Table 158. Chiesi Farmaceutici S.P.A Introduction and Business Overview
    Table 159. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 160. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Offerings
    Table 161. Chiesi Farmaceutici S.P.A Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Pulmonary Drug Delivery Devices Downstream Customers
    Table 165. Pulmonary Drug Delivery Devices Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pulmonary Drug Delivery Devices Product Picture
    Figure 2. Global Pulmonary Drug Delivery Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Pulmonary Drug Delivery Devices Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Pulmonary Drug Delivery Devices Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Pulmonary Drug Delivery Devices Report Years Considered
    Figure 7. Global Pulmonary Drug Delivery Devices Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Pulmonary Drug Delivery Devices Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Drug Delivery Devices Revenue in 2023
    Figure 10. Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Dry Powder Inhaler Picture
    Figure 12. Metered Dose Inhaler Picture
    Figure 13. Nebulizer Picture
    Figure 14. Global Pulmonary Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Pulmonary Drug Delivery Devices Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Pulmonary Drug Delivery Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Pulmonary Drug Delivery Devices Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Pulmonary Drug Delivery Devices Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Asthma
    Figure 20. Product Picture of COPD
    Figure 21. Product Picture of Cystic Fibrosis
    Figure 22. Product Picture of Other
    Figure 23. Global Pulmonary Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Pulmonary Drug Delivery Devices Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Pulmonary Drug Delivery Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Pulmonary Drug Delivery Devices Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Pulmonary Drug Delivery Devices Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Pulmonary Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Pulmonary Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Pulmonary Drug Delivery Devices Sales Volume (%), (2019-2030)
    Figure 40. United States Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Pulmonary Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Pulmonary Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Pulmonary Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
    Figure 61. Pulmonary Drug Delivery Devices Industrial Chain
    Figure 62. Pulmonary Drug Delivery Devices Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Pharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-22Z9081
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global 4-Nitroanisole Reagent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3W15696
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global GC and GC-MS Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-7K9415
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global Pentamidine Isethionate Reagent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1M15643
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

OSZAR »